Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of ONO-4641 in Relapsing-Remitting Multiple Sclerosis
jRCT2080221270Phase 2
- Sponsor
- Ono Pharmaceutical
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ceralifimod in relapsing-remitting multiple sclerosis (RRMS) (3 arms), sponsored by Ono Pharmaceutical.
02
Drugs
ceralifimod
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on jRCT2080221270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221270.